Icosagen is an independent, family-owned Estonia-based biotechnology company, specializing in protein-based biotherapeutics from mammalian cell culture. The company provides integrated discovery, development and GMP manufacturing services for complex biologics.
A €45m expansion enables a seamless, single-site pathway from early protein discovery through CMC development to Phase 1/2 GMP manufacturing for complex biologics.